Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. J of Skin. 2021;5(1):s8. doi:10.25251/skin.5.supp.8